Shortage of AUSTRAPEN ampicillin 1g (as sodium) powder for injection vial (AUST R: 29354)
Updated: Aug 28
Historical supply notice: This article relates to a previous medicine shortage or regulatory approval. Availability and regulatory status may have changed. Healthcare professionals should contact Pro Pharmaceuticals Group to confirm the current supply position.
For current Australian shortage and supply information, see medicine shortages in Australia.
Dear Healthcare Professional,
Shortage of AUSTRAPEN ampicillin 1g (as sodium) powder for injection vial (AUST R: 29354)
Pro Pharmaceuticals Group recognises the importance of supplying essential medicines in Australia and would like to advise you the change in supply status of AUSTRAPEN ampicillin 1g (as sodium) powder for injection vial (AUST R: 29354) in Australia.
The Australian registered medicine AUSTRAPEN ampicillin 1g (as sodium) powder for injection vial sponsored by Alphapharm is currently in shortage due to manufacturing issues.
Pro Pharmaceuticals Group has arranged for the supply of an alternative product,Ampicillin for injection, USP 1g/vial (Mylan, USA). This product is NOT registered in Australia and supply is authorised under an exemption granted by the Therapeutic Goods Administration (TGA) under section 19A of the Therapeutic Goods Act 1989 until 30th November 2023
